Chris Degnan, Chief Financial Officer at Galera Therapeutics, Inc. (GRTX), bought 10,000 shares at $1.96 ($20K) on 2023-03-13, disclosed to the SEC on 2023-03-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| VRCA | BUY | 2018-08-15 | $45K | — | Filing → |